Approval · Notice of Compliance 23345 · 2020
BUSCOPAN: Notice of Compliance 23345
Issued March 16, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23345
- Date
- March 16, 2020
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To propose addition of a new alternate manufacturing site and to revise the labels with new dieliens and dimensions as per the new manufacturing site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BUSCOPAN | Not yet assigned | — |
Medicinal ingredients
- HYOSCINE BUTYLBROMIDE 20 MG per ML